China Health Group Income Statement

Financials in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	39.87	38.94	59.93	76.41	107.03	87.89
Revenue Growth (YoY)	-20.80%	-35.02%	-21.57%	-28.60%	21.77%	94.62%
Cost of Revenue	30.78	29.71	46.29	49.22	78.34	61.9
Gross Profit	9.09	9.24	13.64	27.19	28.69	25.99
Selling, General & Admin	65.83	68.83	50.23	39.99	39.22	37.28
Other Operating Expenses	-16.54	-16.54	-37.7	-	-	-
Operating Expenses	49.29	52.29	12.53	40.02	39.99	38.17
Operating Income	-40.2	-43.06	1.11	-12.82	-11.3	-12.18
Interest Expense	-1.23	-0.25	-0.33	-2.19	-0.29	-0.29
Interest & Investment Income	-	0.01	0.92	0.44	0.33	5.14
Earnings From Equity Investments	-	-	-	-4	-	-
Other Non Operating Income (Expenses)	4.4	-	-	-3.35	-1.9	1.99
EBT Excluding Unusual Items	-37.02	-43.3	1.7	-21.92	-13.16	-5.34
Merger & Restructuring Charges	-	-	-1.33	-	-0.3	-
Impairment of Goodwill	-11.75	-11.75	-13.83	-	-	-
Gain (Loss) on Sale of Investments	-17.64	-17.64	-18.44	-	-	-
Gain (Loss) on Sale of Assets	-2.42	-	3.31	-0.23	-	0.01
Other Unusual Items	8.17	5.31	-13.7	-17.23	4.75	-
Pretax Income	-60.66	-67.38	-42.29	-39.38	-8.71	-5.33
Income Tax Expense	0.38	0.44	0.2	0.18	0.41	1.23
Earnings From Continuing Operations	-61.04	-67.82	-42.5	-39.56	-9.11	-6.56
Minority Interest in Earnings	0.03	0.03	2.31	-2.49	-3.09	-1.19
Net Income	-61.01	-67.79	-40.19	-42.05	-12.21	-7.74
Net Income to Common	-61.01	-67.79	-40.19	-42.05	-12.21	-7.74
Shares Outstanding (Basic)	487	487	475	427	412	412
Shares Outstanding (Diluted)	487	487	475	427	412	412
Shares Change (YoY)	0.43%	2.51%	11.46%	3.48%	-	-
EPS (Basic)	-0.13	-0.14	-0.08	-0.10	-0.03	-0.02
EPS (Diluted)	-0.13	-0.14	-0.08	-0.10	-0.03	-0.02
Free Cash Flow	5.58	-8.35	-7.03	-20.98	31.15	-10.84
Free Cash Flow Per Share	0.01	-0.02	-0.01	-0.05	0.08	-0.03
Gross Margin	22.80%	23.71%	22.76%	35.59%	26.81%	29.57%
Operating Margin	-100.82%	-110.56%	1.85%	-16.78%	-10.56%	-13.86%
Profit Margin	-153.00%	-174.07%	-67.06%	-55.02%	-11.40%	-8.81%
Free Cash Flow Margin	14.00%	-21.45%	-11.72%	-27.46%	29.10%	-12.34%
EBITDA	-37.77	-40.66	3.98	-10.11	-8.38	-9.59
EBITDA Margin	-94.73%	-104.41%	6.64%	-13.23%	-7.83%	-10.91%
D&A For EBITDA	2.43	2.4	2.87	2.72	2.92	2.59
EBIT	-40.2	-43.06	1.11	-12.82	-11.3	-12.18
EBIT Margin	-100.82%	-110.56%	1.85%	-16.78%	-10.56%	-13.86%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.